Cannabis Law Report

AUGUST 10, 2022

According to CAMH’s lead investigator, clinical trials suggest that psilocybin, combined with psychotherapy, can produce “ sustained antidepressant effects” in individuals living with severe depression.

Clinical Trials 52

Clinical Trials Research and Development Therapy Microdosing 52

The Cannigma

DECEMBER 12, 2022

Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving. What is microdosing? A microdose is a dose that does not elicit a perceivable intoxicating or trip-like effect. Microdosing is possible in theory, but there are no current recommendations.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

MARCH 3, 2022

The team at Microdose, the world’s biggest medical psychedelic conference , said the country’s move to permit Med Plant Science Ltd to produce psychedelic compounds makes it the first country to legalize all psychedelic medicine. . The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. and Europe.

Research and Development 52

Research and Development Medicine Clinical Trials Microdosing 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. He is the founder of Apeiron Investment Group, his family office and merchant banking business. Rick Doblin, Ph.D, in/brand-florian/.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51